Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta‐analysis

BACKGROUND: Biologic medications, specifically tumour necrosis factor‐α (TNF‐α) inhibitors, have become increasingly prevalent in the treatment of chronic inflammatory disease (CID) in pregnancy. OBJECTIVE: To determine pregnancy outcomes in women with CID exposed to biologics during pregnancy. SEAR...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Byrne, Laura J., Alqatari, Safi G., Maher, Gillian M., O'Sullivan, Aoife M., Khashan, Ali S., Murphy, Grainne P., McCarthy, Fergus P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306977/
https://www.ncbi.nlm.nih.gov/pubmed/35014759
http://dx.doi.org/10.1111/1471-0528.17093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306977/
https://www.ncbi.nlm.nih.gov/pubmed/35014759
http://dx.doi.org/10.1111/1471-0528.17093

Ejemplares similares